Evidence map›Paper›PMID 29162914›Full record

ArticleScientific reports2017

A small molecule screen to identify regulators of let-7 targets.

J Cinkornpumin, M Roos, L Nguyen, Xiaoguang Liu, X Gaeta, S Lin, D N Chan, A Liu, R I Gregory, M Jung and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Aberrant stem cell and developmental programs in pediatric leukemia.Frontiers in cell and developmental biology · 2024
    Review
  4. ACS medicinal chemistry letters · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Cells · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

J CinkornpuminEli and Edythe Broad Center for Regenerative Medicine, UCLA, California, USA.
M RoosJonsson Comprehensive Cancer Center, UCLA, California, USA.
L NguyenUniversity of Texas-Southwest Medical Center, Texas, USA.
Xiaoguang LiuDepartment of Chemistry, UCLA, California, USA.
X GaetaEli and Edythe Broad Center for Regenerative Medicine, UCLA, California, USA.
S LinStem Cell Program, Boston Children's Hospital, Massachusetts, 02115, USA.
D N ChanDepartment of Molecular Cell and Developmental Biology, UCLA, California, USA.
A LiuDepartment of Molecular Cell and Developmental Biology, UCLA, California, USA.
R I GregoryStem Cell Program, Boston Children's Hospital, Massachusetts, 02115, USA.
M JungDepartment of Chemistry, UCLA, California, USA.
J ChuteJonsson Comprehensive Cancer Center, UCLA, California, USA.
H ZhuUniversity of Texas-Southwest Medical Center, Texas, USA.
W E LowryDepartment of Molecular Cell and Developmental Biology, UCLA, California, USA. blowry@ucla.edu.

Funding

Roles of sumoylation and alternative polyadenylation in cellular reprogrammingP01GM099134 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PLATH, KATHRIN · 2011 to 2021
$20.3M
Reactivation of embryonic growth programs in liver cancerR01CA190525 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI ZHU, HAO · 2015 to 2019
$1.8M
Screening for drugs that restore let-7 microRNA expression in cancerR01CA163467 · NCI · BOSTON CHILDREN'S HOSPITAL · PI GREGORY, RICHARD I. · 2012 to 2016
$1.8M
NCI NIH HHS R01 CA163467NCI NIH HHS R01 CA190525NIGMS NIH HHS P01 GM099134
6 · The paper itself

Abstract

The let-7 family of miRNAs has been shown to be crucial in many aspects of biology, from the regulation of developmental timing to cancer. The available methods to regulate this family of miRNAs have so far been mostly genetic and therefore not easily performed experimentally. Here, we describe a small molecule screen designed to identify regulators of let-7 targets in human cells. In particular, we focused our efforts on the identification of small molecules that could suppress let-7 targets, as these could serve to potentially intercede in tumors driven by loss of let-7 activity. After screening through roughly 36,000 compounds, we identified a class of phosphodiesterase inhibitors that suppress let-7 targets. These compounds stimulate cAMP levels and raise mature let-7 levels to suppress let-7 target genes in multiple cancer cell lines such as HMGA2 and MYC. As a result, these compounds also show growth inhibitory activity on cancer cells.

Indexed as

Cell Line, TumorCell ProliferationCyclic AMP Response Element-Binding ProteinGenes, ReporterHigh-Throughput Screening AssaysHMGA2 ProteinHumansMicroRNAsPhosphodiesterase InhibitorsSmall Molecule LibrariesCyclic AMP Response Element-Binding ProteinHMGA2 ProteinMicroRNAsmirnlet7 microRNA, humanPhosphodiesterase InhibitorsSmall Molecule Libraries

Identifiers

PMID29162914
PMCPMC5698460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.